Human Enhancement Market Research Report: By Technology (Exoskeletons, Smart Devices, Medical Devices, Implants), Application (Healthcare, Defense, Industrial) - Industry Size, Share, and Growth Analysis Forecast to 2030

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Technology

1.3.2 Market Segmentation by Application

1.3.3 Market Segmentation by Region

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Technology

4.1.1.1 Exoskeletons

4.1.1.1.1 Body part

4.1.1.1.1.1 Upper

4.1.1.1.1.2 Lower

4.1.1.1.1.3 Full body

4.1.1.1.2 Form

4.1.1.1.2.1 Hard

4.1.1.1.2.2 Soft

4.1.1.1.3 Actuation

4.1.1.1.3.1 Electric

4.1.1.1.3.2 Hydraulic

4.1.1.1.3.3 Mechanical

4.1.1.2 Smart Devices

4.1.1.2.1 Smart watches and bands

4.1.1.2.2 Smart clothing

4.1.1.2.3 Fitness trackers

4.1.1.2.4 Others

4.1.1.3 Medical Devices

4.1.1.3.1 Bionic lenses

4.1.1.3.2 Hearing aids

4.1.1.3.3 Others

4.1.1.4 Implants

4.1.1.4.1 Passive implants

4.1.1.4.2 Active/sensor implants

4.1.1.4.3 Brain enhancement implants

4.1.2 By Application

4.1.2.1 Healthcare

4.1.2.2 Defense

4.1.2.3 Industrial

4.1.2.4 Others

4.2 Value Chain Analysis

4.3 Market Dynamics

4.3.1 Trends

4.3.1.1 Rising awareness toward adoption of wearables for healthy lifestyle

4.3.1.2 Surging number of advancements in medical technologies

4.3.2 Drivers

4.3.2.1 Increasing utilization of exoskeletons in rehabilitation centers

4.3.2.2 Rising cases of neurological disorders

4.3.2.3 Impact analysis of drivers on market forecast

4.3.3 Restraints

4.3.3.1 High cost and portability issues of exoskeletons

4.3.3.2 Impact analysis of restraints on market forecast

4.3.4 Opportunities

4.3.4.1 Increasing usage of exoskeletons by automotive manufacturing companies

4.3.4.2 Rising implementation of bionic lenses for blind and visually impaired individuals

4.4 Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast

5.1 By Technology

5.1.1 Exoskeleton Market, by Body Part

5.1.2 Exoskeleton Market, by Form

5.1.3 Exoskeleton Market, by Actuation

5.1.4 Smart Devices Market, by Type

5.1.5 Medical Devices Market, by Type

5.1.6 Implants Market, by Type

5.2 By Application

5.3 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Technology

6.1.1 Exoskeleton Market, by Body Part

6.1.2 Exoskeleton Market, by Form

6.1.3 Exoskeleton Market, by Actuation

6.1.4 Smart Devices Market, by Type

6.1.5 Medical Devices Market, by Type

6.1.6 Implants Market, by Type

6.2 By Application

6.3 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Technology

7.1.1 Exoskeleton Market, by Body Part

7.1.2 Exoskeleton Market, by Form

7.1.3 Exoskeleton Market, by Actuation

7.1.4 Smart Devices Market, by Type

7.1.5 Medical Devices Market, by Type

7.1.6 Implants Market, by Type

7.2 By Application

7.3 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Technology

8.1.1 Exoskeleton Market, by Body Part

8.1.2 Exoskeleton Market, by Form

8.1.3 Exoskeleton Market, by Actuation

8.1.4 Smart Devices Market, by Type

8.1.5 Medical Devices Market, by Type

8.1.6 Implants Market, by Type

8.2 By Application

8.3 By Country

Chapter 9. RoW Market Size and Forecast

9.1 By Technology

9.1.1 Exoskeleton Market, by Body Part

9.1.2 Exoskeleton Market, by Form

9.1.3 Exoskeleton Market, by Actuation

9.1.4 Smart Devices Market, by Type

9.1.5 Medical Devices Market, by Type

9.1.6 Implants Market, by Type

9.2 By Application

9.3 By Country

Chapter 10. Competitive Landscape

10.1 List of Players and Their Offerings

10.2 Ranking of Key Players

10.3 Competitive Benchmarking of Key Players

10.4 Strategic Developments of Key Players

10.4.1 Mergers & Acquisitions

10.4.2 Partnerships

10.4.3 Product Launches

10.4.4 Client Wins

Chapter 11. Company Profiles

11.1 ReWalk Robotics Ltd.

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.1.3 Key Financial Summary

11.2 Cyberdyne Inc.

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.2.3 Key Financial Summary

11.3 Medtronic plc

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.3.3 Key Financial Summary

11.4 OMRON Corporation

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.4.3 Key Financial Summary

11.5 Cochlear Ltd.

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.5.3 Key Financial Summary

11.6 Ekso Bionics Holdings Inc.

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.6.3 Key Financial Summary

11.7 Vuzix Corporation

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.7.3 Key Financial Summary

11.8 Garmin Ltd.

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.8.3 Key Financial Summary

11.9 Fitbit Inc.

11.9.1 Business Overview

11.9.2 Products and Services Offerings

11.9.3 Key Financial Summary

11.10 Google LLC

11.10.1 Business Overview

11.10.2 Product and Service Offerings

11.11 Stryker Corporation

11.11.1 Business Overview

11.11.2 Product and Service Offerings

11.11.3 Key Financial Summary

11.12 Zimmer Biomet Holdings Inc.

11.12.1 Business Overview

11.12.2 Product and Service Offerings

11.12.3 Key Financial Summary

11.13 Johnson & Johnson

11.13.1 Business Overview

11.13.2 Product and Service Offerings

11.13.3 Key Financial Summary

11.14 Boston Scientific Corporation

11.14.1 Business Overview

11.14.2 Product and Service Offerings

11.14.3 Key Financial Summary

11.15 Xiaomi Corporation

11.15.1 Business Overview

11.15.2 Product and Service Offerings

11.15.3 Key Financial Summary

11.16 Apple Inc.

11.16.1 Business Overview

11.16.2 Product and Service Offerings

11.16.3 Key Financial Summary

Chapter 12. Appendix

12.1 Abbreviations

12.2 Sources and References

12.3 Related Reports

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2024)

TABLE 5 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2025–2030)

TABLE 6 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2024)

TABLE 7 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2025–2030)

TABLE 8 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2024)

TABLE 9 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2025–2030)

TABLE 10 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2024)

TABLE 11 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2025–2030)

TABLE 12 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 13 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 14 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 15 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 16 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2024)

TABLE 17 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2025–2030)

TABLE 18 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2024)

TABLE 19 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2025–2030)

TABLE 20 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2019–2024)

TABLE 21 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2025–2030)

TABLE 22 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2024)

TABLE 23 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2025–2030)

TABLE 24 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2024)

TABLE 25 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2025–2030)

TABLE 26 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2024)

TABLE 27 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2025–2030)

TABLE 28 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2024)

TABLE 29 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2025–2030)

TABLE 30 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 31 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 32 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 33 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 34 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2024)

TABLE 35 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2025–2030)

TABLE 36 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2024)

TABLE 37 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2025–2030)

TABLE 38 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2024)

TABLE 39 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2025–2030)

TABLE 40 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2024)

TABLE 41 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2025–2030)

TABLE 42 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2024)

TABLE 43 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2025–2030)

TABLE 44 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2024)

TABLE 45 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2025–2030)

TABLE 46 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2024)

TABLE 47 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2025–2030)

TABLE 48 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 49 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 50 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 51 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 52 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2024)

TABLE 53 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2025–2030)

TABLE 54 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2024)

TABLE 55 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2025–2030)

TABLE 56 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2024)

TABLE 57 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2025–2030)

TABLE 58 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2024)

TABLE 59 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2025–2030)

TABLE 60 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2024)

TABLE 61 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2025–2030)

TABLE 62 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2024)

TABLE 63 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2025–2030)

TABLE 64 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2024)

TABLE 65 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2025–2030)

TABLE 66 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 67 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 68 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 69 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 70 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2024)

TABLE 71 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2025–2030)

TABLE 72 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2024)

TABLE 73 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2025–2030)

TABLE 74 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2024)

TABLE 75 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2025–2030)

TABLE 76 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2024)

TABLE 77 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2025–2030)

TABLE 78 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2024)

TABLE 79 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2025–2030)

TABLE 80 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2024)

TABLE 81 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2025–2030)

TABLE 82 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2024)

TABLE 83 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2025–2030)

TABLE 84 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 85 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 86 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2024)

TABLE 87 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2025–2030)

TABLE 88 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2024)

TABLE 89 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2025–2030)

TABLE 90 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2024)

TABLE 91 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2025–2030)

TABLE 92 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2024)

TABLE 93 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2025–2030)

TABLE 94 LIST OF PLAYERS AND THEIR OFFERINGS

TABLE 95 COMPETITIVE BENCHMARKING OF KEY PLAYERS

TABLE 96 REWALK ROBOTICS LTD. – AT A GLANCE

TABLE 97 REWALK ROBOTICS LTD. – KEY FINANCIAL SUMMARY

TABLE 98 CYBERDYNE INC. – AT A GLANCE

TABLE 99 CYBERDYNE INC. – KEY FINANCIAL SUMMARY

TABLE 100 MEDTRONIC PLC – AT A GLANCE

TABLE 101 MEDTRONIC PLC – KEY FINANCIAL SUMMARY

TABLE 102 OMRON CORPORATION – AT A GLANCE

TABLE 103 COCHLEAR LTD. – AT A GLANCE

TABLE 104 COCHLEAR LTD. – KEY FINANCIAL SUMMARY

TABLE 105 VUZIX CORPORATION – AT A GLANCE

TABLE 106 VUZIX CORPORATION – KEY FINANCIAL SUMMARY

TABLE 107 GARMIN LTD. – AT A GLANCE

TABLE 108 GARMIN LTD. – KEY FINANCIAL SUMMARY

TABLE 109 FITBIT INC. – AT A GLANCE

TABLE 110 FITBIT INC.– KEY FINANCIAL SUMMARY

TABLE 111 GOOGLE LLC – AT A GLANCE

TABLE 112 STRYKER CORPORATION – AT A GLANCE

TABLE 113 STRYKER CORPORATION – KEY FINANCIAL SUMMARY

TABLE 114 ZIMMER BIOMET HOLDINGS INC. – AT A GLANCE

TABLE 115 ZIMMER BIOMET HOLDINGS INC. – KEY FINANCIAL SUMMARY

TABLE 116 JOHNSON & JOHNSON – AT A GLANCE

TABLE 117 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY

TABLE 118 BOSTON SCIENTIFIC CORPORATION – AT A GLANCE

TABLE 119 BOSTON SCIENTIFIC CORPORATION – KEY FINANCIAL SUMMARY

TABLE 120 XIAOMI CORPORATION – AT A GLANCE

TABLE 121 XIAOMI CORPORATION – KEY FINANCIAL SUMMARY

TABLE 122 APPLE INC. – AT A GLANCE

TABLE 123 APPLE INC. – KEY FINANCIAL SUMMARY

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL HUMAN ENHANCEMENT MARKET SUMMARY

FIG 9 VALUE CHAIN ANALYSIS OF GLOBAL HUMAN ENHANCEMENT MARKET

FIG 10 BARGAINING POWER OF BUYERS

FIG 11 BARGAINING POWER OF SUPPLIERS

FIG 12 INTENSITY OF RIVALRY

FIG 13 THREAT OF NEW ENTRANTS

FIG 14 THREAT OF SUBSTITUTES

FIG 15 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2030)

FIG 16 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2030)

FIG 17 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2030)

FIG 18 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2030)

FIG 19 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 20 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 21 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2030)

FIG 22 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2030)

FIG 23 WORLDWIDE MAJOR MARKETS FOR HUMAN ENHANCEMENT DEVICES

FIG 24 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2019–2030)

FIG 25 NORTH AMERICA HUMAN ENHANCEMENT MARKET SNAPSHOT

FIG 26 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2030)

FIG 27 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2030)

FIG 28 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2030)

FIG 29 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2030)

FIG 30 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 31 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 32 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2030)

FIG 33 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2030)

FIG 34 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2030)

FIG 35 EUROPE HUMAN ENHANCEMENT MARKET SNAPSHOT

FIG 36 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2030)

FIG 37 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2030)

FIG 38 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2030)

FIG 39 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2030)

FIG 40 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 41 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 42 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2030)

FIG 43 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2030)

FIG 44 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2030)

FIG 45 APAC HUMAN ENHANCEMENT MARKET SNAPSHOT

FIG 46 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2030)

FIG 47 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2030)

FIG 48 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2030)

FIG 49 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2030)

FIG 50 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 51 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 52 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2030)

FIG 53 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2030)

FIG 54 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2030)

FIG 55 ROW HUMAN ENHANCEMENT MARKET SNAPSHOT

FIG 56 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2019–2030)

FIG 57 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2019–2030)

FIG 58 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2019–2030)

FIG 59 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2019–2030)

FIG 60 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 61 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2019–2030)

FIG 62 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2019–2030)

FIG 63 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2019–2030)

FIG 64 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2019–2030)

FIG 65 RANKING OF KEY PLAYERS IN GLOBAL HUMAN ENHANCEMENT MARKET (2023)

FIG 66 REWALK ROBOTICS LTD. – REVENUE SPLIT BY GEOGRAPHY (2023)

FIG 67 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 68 OMRON CORPORATION – KEY FINANCIAL SUMMARY

FIG 69 OMRON CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 70 COCHLEAR LTD. – REVENUE SPLIT BY PRODUCT LINE AND GEOGRAPHY (2023)

FIG 71 EKSO BIONICS HOLDINGS INC. – AT A GLANCE

FIG 72 EKSO BIONICS HOLDINGS INC. – KEY FINANCIAL SUMMARY

FIG 73 EKSO BIONICS HOLDINGS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 74 VUZIX CORPORATION – REVENUE SPLIT BY GEOGRAPHY (2023)

FIG 75 GARMIN LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 76 FITBIT INC. – REVENUE SPLIT BY GEOGRAPHY (2023)

FIG 77 STRYKER CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 78 ZIMMER BIOMET HOLDINGS INC. – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2023)

FIG 79 JOHNSON & JOHNSON – REVENUE SPLIT BY BUSINESS SEGMENT AND GEOGRAPHY (2023)

FIG 80 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 81 XIAOMI CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 82 APPLE INC. – REVENUE SPLIT BY GEOGRAPHY (2023)